Huarun Pharmacy (300110.SZ) released its half-yearly results, with a net profit attributable to shareholders of 37.33 million yuan, a year-on-year decrease of 49.01%.

Sina Finance News: Huarisco Pharmaceuticals (300110.SZ) released its 2025 semi-annual report. During the reporting period, the company achieved operating income of 624 million yuan, a year-on-year decrease of 19.13%. The net profit attributable to the shareholders of the listed company was 37.3329 million yuan, a year-on-year decrease of 49.01%. The net profit attributable to the shareholders of the listed company after deducting non-recurring gains and losses was 27.6892 million yuan, a year-on-year decrease of 59.17%. Basic earnings per share were 0.0316 yuan.